IN 119873
Alternative Names: IN-119873; IN-A008Latest Information Update: 20 Jun 2024
At a glance
- Originator CJ Cheiljedang Corp.
- Developer HK inno.N
- Class Antineoplastics; Benzamides; Isoindoles
- Mechanism of Action Epidermal growth factor receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes
Highest Development Phases
- Preclinical Non-small cell lung cancer
Most Recent Events
- 05 Apr 2024 Pharmacodynamics data from preclinical trial in Non-small cell lung cancer presented at the 115th Annual Meeting of the American Association for Cancer Research (AACR-2024)
- 29 Mar 2024 HK inno.N plans to submit IND application in Non-small cell lung cancer in 2024
- 28 Mar 2024 IN 119873 is available for licensing as of 28 Mar 2024. https://www.inno-n.com/eng/esg/csr/co_prosperity/esg_support